SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
64 hedge funds and large institutions have $266M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
Holders
64
Holding in Top 10
3
Calls
$611K
Puts
–
Top Buyers
| 1 | +$13.5M | |
| 2 | +$4.87M | |
| 3 | +$3M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$1.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$851K |
Top Sellers
| 1 | -$3.63M | |
| 2 | -$1.48M | |
| 3 | -$892K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$383K |
| 5 |
D.E. Shaw & Co
New York
|
-$369K |